Vanda Pharmaceuticals | VNDA - Ebit





Ebit Cambiamento Data
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -249.71M 11.64M 2025-12
J&J USD 6.62B 1.51B 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Merck USD -1.88B 8.12B 2026-03
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sanofi EUR 1.94B 239M 2026-03
Takeda JPY 257.49B 568.56B 2025-12
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Veracyte USD 24.63M 1.52M 2025-12